4 unknown, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Active not recruiting 1 |
| Phase 3 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow GR1802 injection: new trials by email Literature Review of GR1802 injection trials Research Report on GR1802 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Not yet recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 144 | 2025-09-25 | 2025-09-30 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2025-08-15 | 2025-09-04 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). GR1802 injection, Placebo - Allergic Rhinitis | Phase 2 | Active not recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 240 | 2024-03-24 | 2025-04-25 |
| Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis GR1802 injection, placebo - Atopic Dermatitis | Phase 3 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 450 | 2024-01-01 | 2024-01-22 |
| The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps GR1802 injection - Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 70 | 2023-08-18 | 2023-08-29 |
| The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps GR1802 injection, placebo - Chronic Rhinosinusitis with Nasal Polyps | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 70 | 2023-02-08 | 2024-09-25 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma GR1802 injection, Placebo - Asthma | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2022-07-19 | 2024-10-15 |
Rhinitis, Allergic, Seasonal (2) · Asthma (1) · Dermatitis, Atopic (1) · Rhinitis, Allergic (1)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. (7)
China (6)
Zheng Liu, PHD (1)